monarchE: primary overall survival (OS) results of adjuvant abemaciclib (abema) plus endocrine therapy (ET) for HR+, HER2-, high-risk early breast cancer (EBC) [Abstract]

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Nina DitschORCiDGND, Stephen Johnston, Miguel Martin, Joyce O'Shaughnessy, Roberto Hegg, Sara Tolaney, Valentina Guarneri, Lucia Del Mastro, Mario Campone, Javier Cortez, Hope S. Rugo, Matthew P. Goetz, Erika Hamilton, Elzbieta Senkus, Laura Testa, Patrick Neven, Jens Huober, Ran Wei, Maria Munoz, Priya Rastogi, Nadia Harbeck
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/130734
ISSN:2296-5270OPAC
ISSN:2296-5262OPAC
Parent Title (English):Oncology Research and Treatment
Publisher:S. Karger
Place of publication:Basel
Type:Article
Language:English
Date of Publication (online):2026/05/29
Year of first Publication:2026
Publishing Institution:Universität Augsburg
Release Date:2026/06/10
Volume:49
Issue:Supplement 1
First Page:254
Last Page:255
DOI:https://doi.org/10.1159/000550849
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Professur für Operative und Konservative Senologie
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit